Investors who bought shares in this Dividend Aristocrat in 2019 have already got a third of their cash back

British American Tobacco shares have generated plenty of dividends in the last few years. But Stephen Wright says investors could have done better.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Image source: British American Tobacco

Investors who bought British American Tobacco (LSE: BATS) shares five years ago have already received 32% of their investment back in dividends. That’s a lot.

By contrast, investors who bought shares in Bunzl (LSE:BNZL) have received less than 14% of their initial outlay back. But that doesn’t tell the full story.

Dividends

While British American Tobacco has sent out a lot of cash to its shareholders, the total return has been much lower. This is the result of a falling share price.

The firm has sent out £10.51 per share. But the stock is down by £3.89, which means investors who bought the stock at the end of 2019 are actually up £6.62 per share.

At the end of 2019, the share price was £32.66, so £6.62 translates into a return of just over 20%. That’s worse than the FTSE 100 over the same time period. 

It’s natural to think that the dividend should be the main focus for investors looking for passive income. But investors should be wary of falling into a trap here.

Growth

Bunzl’s dividend has been much lower, but it has more than made up for this with growth. As earnings have gone from £1.05 to £1.56, the stock has climbed 55%.

This has allowed shareholders to sell part of their stake to generate cash. In this way, they’ve been able to match the 42% distributed by British American Tobacco.

Furthermore, investors who bought Bunzl shares have been able to do this while still having an investment worth more than they paid for it. This is important.

A stock doesn’t have to pay a dividend to create a passive income opportunity – growth can do this just as well. But there are risks with either strategy.

Risks and rewards

With British American Tobacco, the product that makes up most of its revenues is probably in terminal decline. So the durability of the dividend is questionable.

This doesn’t automatically make the stock a bad choice. But investors need to be confident they’re going to get enough in distributions to offset the business contracting.

Bunzl’s operation is growing, rather than shrinking. But with a 2% dividend yield, the firm needs to find enough growth to be able to generate a return for investors.

The key is finding enough acquisition opportunities. If it can’t it will be hard for the company to maintain the kind of returns it has managed over the last five years.

Total return

Shares with high dividend yields can be attractive for passive income investors. But a growth stock that lets investors take cash out can be just as good.

Ultimately, investment results are the same whether they come directly from the company or by investors selling shares. Either can provide a cash return.

Stephen Wright has no position in any of the shares mentioned. The Motley Fool UK has recommended British American Tobacco P.l.c. and Bunzl Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »